RELAY THERAPEUTICS INC. - COMMON STOCK

Relay Therapeutics to Participate in Upcoming Investor Conferences

11 أبريل 2024 16:05:14 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Three Upcoming Investor Conferences

26 فبراير 2024 16:05:17 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights

22 فبراير 2024 16:05:19 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Corporate Highlights on February 22, 2024

15 فبراير 2024 16:05:27 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference

01 فبراير 2024 16:05:05 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces $30 Million Private Placement Financing

08 يناير 2024 07:00:32 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present at 42nd Annual J.P. Morgan Healthcare Conference

02 يناير 2024 16:05:12 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Stifel 2023 Healthcare Conference

07 نوفمبر 2023 16:05:18 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Third Quarter 2023 Financial Results and Corporate Highlights

02 نوفمبر 2023 16:05:42 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Third Quarter 2023 Financial Results and Corporate Highlights on November 2, 2023

26 أكتوبر 2023 16:05:51 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial RLY-4008 (lirafugratinib) Data Demonstrating Durable Responses Across Multiple FGFR2-Altered Solid Tumors

12 أكتوبر 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Present Clinical Data on RLY-4008 in Advanced FGFR2-Altered Solid Tumors at 2023 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

18 سبتمبر 2023 16:05:42 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports Second Quarter 2023 Financial Results and Corporate Highlights

08 أغسطس 2023 16:02:09 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce Second Quarter 2023 Financial Results and Corporate Highlights on August 8, 2023

01 أغسطس 2023 16:05:24 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Full Dose Escalation Data for RLY-4008

25 مايو 2023 17:01:31 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

24 مايو 2023 16:05:03 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Reports First Quarter 2023 Financial Results and Corporate Highlights

04 مايو 2023 16:05:47 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Announce First Quarter 2023 Financial Results and Corporate Highlights

27 أبريل 2023 16:05:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics to Participate in Two Upcoming Investor Conferences

19 أبريل 2023 07:30:00 بحسب Nasdaq GlobeNewswire

Relay Therapeutics Announces Initial Clinical Data Demonstrating that RLY-2608 Selectively Targets Multiple PI3Kα Mutations

18 أبريل 2023 10:40:00 بحسب Nasdaq GlobeNewswire